These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor. Lepäntalo A, Virtanen KS, Reséndiz JC, Mikkelsson J, Viiri LE, Karhunen PJ, Lassila R. Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433 [Abstract] [Full Text] [Related]
5. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, Bray PF, Kleiman NS. J Am Coll Cardiol; 2006 Jan 03; 47(1):27-33. PubMed ID: 16386660 [Abstract] [Full Text] [Related]
8. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N. J Am Coll Cardiol; 2009 Mar 10; 53(10):849-56. PubMed ID: 19264241 [Abstract] [Full Text] [Related]
12. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial. Serebruany VL, Malinin AI, Jerome SD, Lowry DR, Morgan AW, Sane DC, Tanguay JF, Steinhubl SR, O'connor CM. Am Heart J; 2003 Oct 10; 146(4):713-20. PubMed ID: 14564328 [Abstract] [Full Text] [Related]
13. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients. Cuisset T, Frere C, Quilici J, Gaborit B, Castelli C, Poyet R, Bali L, Morange PE, Alessi MC, Bonnet JL. Am J Cardiol; 2009 Oct 15; 104(8):1078-82. PubMed ID: 19801028 [Abstract] [Full Text] [Related]
15. Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease. Mazur P, Frołow M, Niżankowski R, Sadowski J, Undas A. Platelets; 2013 Oct 15; 24(2):151-5. PubMed ID: 22497730 [Abstract] [Full Text] [Related]
16. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C. Thromb Res; 2005 Oct 15; 116(6):491-7. PubMed ID: 16181985 [Abstract] [Full Text] [Related]
17. Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel. Lev EI, Patel RT, Guthikonda S, Lopez D, Bray PF, Kleiman NS. Thromb Res; 2007 Oct 15; 119(3):355-60. PubMed ID: 16581111 [Abstract] [Full Text] [Related]
18. Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene. Staritz P, Kurz K, Stoll M, Giannitsis E, Katus HA, Ivandic BT. Int J Cardiol; 2009 Apr 17; 133(3):341-5. PubMed ID: 18485500 [Abstract] [Full Text] [Related]
19. Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents. Schulz S, Sibbing D, Braun S, Morath T, Mehilli J, Massberg S, Byrne RA, Schömig A, Kastrati A. Am Heart J; 2010 Aug 17; 160(2):355-61. PubMed ID: 20691843 [Abstract] [Full Text] [Related]
20. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin. Dropinski J, Jakiela B, Sanak M, Wegrzyn W, Biernat M, Dziedzina S, Plutecka H, Szczeklik A. Thromb Haemost; 2007 Jul 17; 98(1):201-9. PubMed ID: 17598014 [Abstract] [Full Text] [Related] Page: [Next] [New Search]